Is this you? Create Your Porfile

Michael J. Morin

New York State Department of Health

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Michael J. Morin is active.

Explore More

Publication

Featured researches published by Michael J. Morin.

Cancer Research | 1997

Induction of Apoptosis and Cell Cycle Arrest by CP-358,774, an Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinase

James D. Moyer; Elsa G. Barbacci; Kenneth K. Iwata; Lee Daniel Arnold; Bruce M. Boman; Ann Cunningham; Catherine DiOrio; Jonathan Doty; Michael J. Morin; Mikel P. Moyer; Mark J. Neveu; Vincent A. Pollack; Leslie R. Pustilnik; Margaret M. Reynolds; Don Sloan; April Theleman; Penny Miller

Journal of Pharmacology and Experimental Therapeutics | 1999

Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice

Vincent A. Pollack; Douglas Savage; Deborah A. Baker; Konstantinos E. Tsaparikos; Donald E. Sloan; James D. Moyer; Elsa G. Barbacci; Leslie R. Pustilnik; Teresa A. Smolarek; John M. Davis; Madhur P. Vaidya; Lee Daniel Arnold; John L. Doty; Kenneth K. Iwata; Michael J. Morin

Cancer Research | 1984

Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.

Michael J. Morin; Alan C. Sartorelli

Journal of Cellular Physiology | 1983

The biochemical and ultrastructural effects of tunicamycin and D‐glucosamine in L1210 leukemic cells

Michael J. Morin; Carl W. Porter; Patricia McKernan; Ralph J. Bernacki

Journal of Medicinal Chemistry | 1980

Halogenated L-fucose and D-galactose analogues: synthesis and metabolic effects.

Janice R. Sufrin; Ralph J. Bernacki; Michael J. Morin; Walter Korytnyk

Cancer Research | 1983

Biochemical Effects and Therapeutic Potential of Tunicamycin in Murine L1210 Leukemia

Michael J. Morin; Ralph J. Bernacki

Biochemical Pharmacology | 1983

Effects of a membrane sugar analogue, 6-deoxy-6-fluoro-d-galactose, on the L1210 leukemic cell ectosialyltransferase system

Michael J. Morin; Carl W. Porter; Charles R. Petrie; Walter Korytnyk; Ralph J. Bernacki

Archive | 2000

Polymorphe stable de chlorhydrate de n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, et methodes de production et utilisations pharmaceutiques dudit polymorphe

Richard D. Connell; James D. Moyer; Michael J. Morin; Shama Kajiji; Barbara A. Foster; Karen J. Ferrante; Timothy Norris; Jeffrey W. Raggon; Sandra L Silberman

Archive | 2000

POLIMORFO ESTABLE DE CLORHIDRATO DE N-(3-ETINILFENILAMINO)-6,7-BIS(2-METOXIETOXI)-4-QUINAZOLINAMINA,PROCEDIMIENTOS DE PRODUCCION Y USOS FARMACEUTICOS DEL MISMO.

Richard D. Connell; Karen J. Ferrante; Barbara A. Foster; Shama Kajiji; Michael J. Morin; James D. Moyer; Timothy Norris; Jeffrey W. Raggon; Sandra L Silberman

Archive | 2000

N-(3-ethinylphenylamino)-6,7-bis(2-methoxyethoxy)-4-chinazolinamin zur behandlung von nsclc

Richard D. Connell; James D. Moyer; Michael J. Morin; Shama Kajiji; Barbara A. Foster; Karen J. Ferrante; Timothy Norris; Jeffrey W. Raggon; Sandra L Silberman

Explore More